Prevention and control of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: need for a multimodal approach
- PMID: 32016043
- PMCID: PMC6976407
- DOI: 10.21037/atm.2019.09.130
Prevention and control of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: need for a multimodal approach
Conflict of interest statement
Conflicts of Interest: E Durante-Mangoni received grant support and speaker’s honoraria from Pfizer, MSD, Angelini, Bio-Merieux, Abbvie, Sanofi-Aventis, Medtronic, and DiaSorin. The other authors have no conflicts of interest to declare.
Figures
Comment on
-
Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study.Antimicrob Resist Infect Control. 2019 Jan 10;8:8. doi: 10.1186/s13756-018-0453-7. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 30651974 Free PMC article.
References
-
- Li M, Wang X, Wang J, et al. Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study. Antimicrob Resist Infect Control 2019;8:8. 10.1186/s13756-018-0453-7 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources